期刊文献+

重组鼠干细胞因子的原核表达、纯化及生物活性初步分析

Prokaryotic Expression, Purification and Primary Bioactivity Assay for Recombinant Mouse Stem Cell Factor
下载PDF
导出
摘要 目的:研制重组鼠干细胞因子(rmSCF),并检测其体外生物学活性。方法:提取BALB/c孕龄鼠总RNA,通过RT-PCR扩增mSCF的编码基因,将其克隆至原核表达载体pBV220,转化大肠杆菌DH5α,将重组菌株接种至氨苄青霉素抗性的LB培养基中,扩大培养至5L发酵罐中,42℃诱导表达,经包涵体复性、DEAE-SepharoseFF和Phenyle-SepharoseHP层析纯化,制备rmSCF。结果:构建了pBV220-mSCF原核表达载体,在大肠杆菌中表达了rmSCF,纯化后的rmSCF对类原巨核细胞白血病细胞系的UT-7细胞有明显的刺激作用,比活为1.0×106U/mg。结论:获得了纯度大于95%的rmSCF,将进一步展开其在小鼠体内的药效学研究。 Objective: To express and purify recombinant mouse stem cell factor(nnSCF) in Escherichia coli, and analyze its bioactivity in vivo. Methods: Total mRNA was extracted from the embryonic liver from pregnant BALB/c mice, from which the gene encoding mSCF was amplified by RT-PCR. The PCR product was confirmed by sequence analysis, and was cloned into pBV220 to construct expression plasmid pBV220-mSCF, and then it was transformed into E.coli DH5oc The recombinant strain was inoculated into LB with ampicillin resistance and scaled up to the 5 liter fermentor, the recombinant mSCF protein was expressed when induced at temperature of 42℃. The rmSCF expressed as the inclusion body was renatured and purified by DEAE-sepharose FF and phenyle-sepharose HP chromatography. Its bioactivity of proliferation stimulation of megakaryocytic leukemic cell UT-7 was analyzed. Results: The prokaryotic expression vector pBV220- mSCF was constructed and rmSCF was expressed in E.coli efficiently. The purified rmSCF stimulated megakaryocytic leukemia cell UT-7 proliferation and its specific activity was 1.0×10^6 U/rag. Conclusion: The rmSCF with a purity of 95% was produced, and it will be subjected to the pharmacodynamic study in mice.
出处 《生物技术通讯》 CAS 2009年第3期350-352,共3页 Letters in Biotechnology
关键词 鼠干细胞因子 原核表达 蛋白纯化 mouse stem cell factor prokaryotic expression protein purification
  • 相关文献

参考文献8

  • 1Williams D E, Eisenman J, Baird A, et al. Identification of a lig-and for the c-kit proto -oncogene[J]. Cell, 1990,63(2):167-174.
  • 2Zsebo K M Wypych J, McNiece I K, et al. Identification,purification,and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium[J]. Cell, 1990,63(2):195- 201.
  • 3Huang E, Nocka K, Beier D R, et al. The hematopoietic growth factor KL is eneDed by the S1 locus and is the ligand of the c-kit receptor, the gene product of the W locus[J]. Cell, 1990,63(2): 225-233.
  • 4Stiff P, Gingrich R, Luger S, et al. A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with HDgkin's disease or non-HDgkin's lymphoma[J]. Bone Marrow Transplant, 2000,26(5):471-481.
  • 5Wadhwa P D, Lazarus H M, Koc O N, et al. Hematopoietic recovery after unrelated umbilical cord-bloD allogeneic transplantation in adults treated with in vivo stem cell factor(R-MetHuSCF) and filgrastim administration[J]. Leuk Res, 2003,27(3):215-220.
  • 6Duarte R F, Franf D A. The synergy between stem cell factor and granulocyte colony-stimulating factor: molecular basis and clinical relevance[J]. Leuk Lymphoma, 2002,43(6):1179-1187.
  • 7吴军,巩新,唱韶红,赵志虎,马清钧.重组人干细胞因子的纯化[J].中国生物化学与分子生物学报,2004,20(6):821-826. 被引量:2
  • 8吴军,巩新,唱韶红,赵志虎,左从林,马清钧.重组人干细胞因子的研究[J].生物工程学报,2003,19(6):698-704. 被引量:2

二级参考文献21

  • 1Williams D E, Eisenman J, Baird A, Rauch C, Van Ness K, March C J,Park L S, Martin U, Mochizuki D Y, Boswell H S, Burgess G S, Cosman D, Lynan S D. Identification of a ligand for the c-kit proto -oncogene.Cell, 1990,63(2): 167 ~ 174
  • 2Zsebo K M, Wypych J,McNiece I K,Lu H S,Smith K A,Karkare S B,Sachder R K, Yuschenkoff V N, Birkett N C, Williams L R.Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell, 1990,63(2): 195 ~ 201
  • 3Huang E, Nocka K, Beier D R, Chu F Y, Buck J, Lahm H W, Wellner D,Leder P, Besmer P. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor,the gene product of the W locus. Cell, 1990,63(2):225 ~ 233
  • 4Brugger W, Heimfeld S, Berenson R J, Mertelsman R, Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cell generated ex vivo . New England J Med , 1995,333(5) :283 ~ 287
  • 5van de Yen C ,Ishizawa L , Law P,Cairo M S. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34 + cell population from cord blood vs. adult bone marrow. Exp Hematol , 1995,23(12): 1289 ~ 1295
  • 6Stiff P, Gingrich R, Luger S,Wyres M R,Brown R A,Lemaistre C F, Perry J, Schenkein D P, List A, Mason J R, Bensinger W, Wheeler C,Freter C, Parker W R L, Emmanouilides C. A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin' s disease or non-Hodgkin' s lymphoma. Bone Marrow Transplant. 2000,26(5) :471 ~ 481
  • 7Wadhwa P D, Lazarus H M, Koc O N, Jaroscak J, Woo D, Stevens C E,Rubinstein P, Laughlin M T. Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administration. Leuk Res. 2003, 27(3) :215 ~ 220
  • 8Duarte R F, Franf D A. The synergy between stem cell factor (SCF)and granulocyte colony-stimulating factor (G-CSF): molecular basis and clinical relevance. Leuk Lymphoma. 2002,43(6): 1179 ~ 1187
  • 9Langley K E, Wypych J, Mendiaz E A, Clogston C L, Parker V P, Farrar D H, Brothers M O, Satygal V N, Leslie I, Birkett N C. Purification and characterization of soluble forms of human and rat stem cell factor recombinantly expressed by Escherichia coli and by Chinese hamster ovary cells. Arch Biochem Biophys, 1992,295(1): 21 ~ 28
  • 10Williams D E,Eisenman J,Baird A et al.Identification of a ligand for the c-kit proto-oncogene. Cell,1999,63(2):167-174

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部